Vicarious Surgical (RBOT) Cash & Equivalents (2020 - 2025)

Vicarious Surgical (RBOT) has 6 years of Cash & Equivalents data on file, last reported at $2.6 million in Q4 2025.

• On a quarterly basis, Cash & Equivalents fell 73.62% year-over-year to $2.6 million in Q4 2025; TTM through Dec 2025 was $2.6 million, a 73.62% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, down 73.62% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $2.6 million, down from $13.4 million in the prior quarter.
• Over the last five years, Cash & Equivalents for RBOT reached as high as $185.0 million in Q3 2021 and fell as low as $1.0 million in Q1 2021.
• Historically, Cash & Equivalents has averaged $66.0 million across 5 years, with a median of $52.0 million in 2023.
• Across the five-year window, Cash & Equivalents soared 15173.98% in 2022 and sank 88.04% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $173.5 million in 2021, then sank by 33.02% to $116.2 million in 2022, then tumbled by 33.87% to $76.8 million in 2023, then sank by 87.33% to $9.7 million in 2024, then sank by 73.62% to $2.6 million in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $2.6 million in Q4 2025, $13.4 million in Q3 2025, and $3.9 million in Q2 2025.